Targeting CDK7 in oncology: The avenue forward-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting CDK7 in oncology: The avenue forward

Published:2022-12 Issue: Volume:240 Page:108229
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Li Zhi-Mei,Liu Guan,Gao Ya,Zhao Ming-Gao

Funder

National Natural Science Foundation of China

Natural Science Foundation of Shaanxi Province

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference140 articles.

1. CT7001: An orally bioavailable CDK7 inhibitor is a potential therapy for breast, small-cell lung and haematological cancers;Ainscow;Cancer Research,2018

2. The development of a selective cyclin-dependent kinase inhibitor that shows antitumor activity;Ali;Cancer Research,2009

3. Targeting CDK7 reverses tamoxifen resistance through regulating stemness in ER+ breast cancer;Attia;Pharmacological Reports,2022

4. Blockade of CDK7 reverses endocrine therapy resistance in breast cancer;Attia;International Journal of Molecular Sciences,2020

5. FDA approval: Palbociclib for the treatment of postmenopausal patients with Estrogen receptor-positive, HER2-negative metastatic breast cancer;Beaver;Clinical Cancer Research,2015

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of bivalent small molecule degraders of cyclin-dependent kinase 7 (CDK7);European Journal of Medicinal Chemistry;2024-10

2. Targeting cyclin-dependent kinases: From pocket specificity to drug selectivity;European Journal of Medicinal Chemistry;2024-09

3. Activation of the CDK7 Gene, Coding for the Catalytic Subunit of the Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) and General Transcription Factor II H, by the Trans-Activator Protein Tax of Human T-Cell Leukemia Virus Type-1;Genes;2024-08-15

4. Adenovirus vaccine targeting kinases induces potent antitumor immunity in solid tumors;Journal for ImmunoTherapy of Cancer;2024-08

5. The anti-neoplastic impact of thymoquinone from Nigella sativa on small cell lung cancer: In vitro and in vivo investigations;Journal of Cancer Research and Therapeutics;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3